Papers: 10.1128/AAC.01949-19

https://doi.org/10.1128/AAC.01949-19

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial

Cited by: 27
Author(s): Sandra P. McCurdy, Kara Keedy, Laura Lawrence, Ashley Nenninger, Amanda Sheets, Megan Quintas, Sue Cammarata
Published: over 6 years ago

Software Mentions 1